Read the finding with its subject attached
The current Cialis prescribing information states that as-needed tadalafil improved erectile function compared with placebo up to 36 hours after dosing. The subject is erectile function in the studied treatment setting. It is not a claim that a person should remain erect for that period, and it does not promise the same response at every moment for every patient. [Cialis prescribing information]
That distinction matters when a sales page turns a duration into a lifestyle phrase. A useful question for the clinician is what to expect from your actual prescription and how to recognize a response that needs review. A headline cannot answer those individual questions.
The medicine does not replace sexual stimulation
Both the label and MedlinePlus explain the role of sexual stimulation in tadalafil's effect on erections. MedlinePlus also states that tadalafil does not increase sexual desire. A longer period in which erectile function may improve should not be interpreted as continuous arousal or a requirement to attempt sex throughout that period. [MedlinePlus]
If desire, pain, anxiety or another concern is part of the difficulty, describe it during the assessment. NIDDK's treatment overview includes approaches beyond oral medicine, including counseling when appropriate. A duration comparison is only one piece of the wider care discussion. [NIDDK]
A duration claim is not a medication safety timer
Do not use the end of an advertised window to decide when another ED medicine, nitrate or other interacting drug becomes safe. The Cialis label contains specific interaction warnings and medical circumstances that can change exposure. Emergency clinicians need to know that you use tadalafil and when it was last taken. A personal plan belongs with the treating team. [Label]
An erection lasting longer than four hours requires emergency medical attention, whether or not it is painful. That is a warning sign, not evidence that the advertised duration is working especially well. Sudden loss of vision or hearing also calls for prompt medical attention and stopping PDE5 inhibitor use as directed in the label. [Safety information]
Keep tadalafil findings attached to tadalafil
Our sponsored listing, CoreAge Rx 4Play, is a compounded liquid containing tadalafil plus apomorphine, sildenafil and vardenafil. The tadalafil-alone finding does not establish a 36-hour benefit for that combination. FDA does not approve compounded products, and the Cialis label warns against combining it with other PDE5 inhibitors. [4Play ingredients] [FDA]
Read the preparation guide before carrying any timing claim from one product to another. If the wording around a prescription remains unclear, use the follow-up guide to ask the clinician for an explanation tied to the medicine actually supplied.
Where to read more
Source pages checked October 6, 2026. Provider pages describe their advertised services. Medical references do not endorse this publication or its sponsor.
- Cialis: Manufacturer prescribing information, revised March 2026Eli Lilly approved labeling on DailyMed
- MedlinePlus: TadalafilPatient medication information
- NIDDK: Treatment for erectile dysfunctionFederal patient information
- FDA: Compounding questions and answersRegulatory explanation
- CoreAge Rx: 4Play product informationSponsored provider; advertised formulation